Artery blood vessel automatic tracking method and device based on silicon-based photons and wearable equipment
By generating a blood flow distribution heatmap using a combination of silicon-based photonic microring resonators and selecting the microring resonator with the highest signal-to-noise ratio as the central measurement channel, the problem of arterial location and tracking in wearable devices is solved, enabling real-time and seamless blood pressure monitoring.
Patent Information
- Application Number
- CN202512032267.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2025-12-30
- Publication Date
- 2026-04-14
AI Technical Summary
Existing wearable blood pressure monitoring devices suffer from high position sensitivity, ambiguous zero-difference detection direction, and low signal-to-noise ratio in signal acquisition, which makes it impossible to accurately locate and track the position of arteries in real time, resulting in signal loss.
A combination of silicon-based photonic microring resonators is used to generate a blood flow distribution heatmap by polling the microring resonators to receive reflected signals. The microring resonator with the highest signal-to-noise ratio is selected as the central measurement channel and repositioned when the signal-to-noise ratio decreases. The microring resonators are integrated on a silicon-based photonic chip to form a two-dimensional array, thereby realizing automatic tracking of arterial blood vessels.
It enables rapid and accurate location and tracking of arterial vessels even with sensor displacement, solving the signal loss problems caused by alignment and displacement of traditional single-point sensors, and providing continuous and non-invasive blood pressure monitoring capabilities.
Smart Images

Figure CN121845536A_ABST
Abstract
Description
Technical Field
[0001] This invention belongs to the field of vascular tracking and positioning technology, specifically relating to an automatic arterial vascular tracking method, device, and wearable device based on silicon photonics. Background Technology
[0002] Cardiovascular disease (CVD) is a leading cause of death worldwide, with hypertension affecting over a billion people. Hypertension is known as the "silent killer," its danger lying not only in the absolute value of blood pressure but also in its variability (BPV) and abnormal circadian rhythms (such as non-dipper hypertension). Traditional cuff blood pressure monitors only provide intermittent, static measurements and cannot capture dynamic changes in blood pressure during daily life or sleep, limiting their predictive ability for acute cardiovascular events such as stroke and myocardial infarction.
[0003] Therefore, achieving cuffless, continuous, and non-invasive blood pressure monitoring (CNIBPM) has become the "holy grail" of the medical technology field. However, existing wearable solutions face insurmountable bottlenecks in the physical mechanisms of signal acquisition.
[0004] Currently, wearable devices based on traditional laser Doppler velocimetry (LDV) technology face significant obstacles in practical applications.
[0005] The alignment challenge of "single-point" measurement: Traditional LDV typically uses a single-beam laser focusing. The radial artery is only 2-3 millimeters in diameter, meaning the sensor must be precisely aligned above the blood vessel. In wrist-worn scenarios, even slight slippage can cause the laser beam to deviate from the blood vessel and enter static tissue, resulting in instantaneous signal loss. This extremely high "position sensitivity" makes single-point LDV difficult to use in uncontrolled environments.
[0006] Homodyne detection suffers from directional ambiguity: Most low-cost LDV systems employ homodyne detection, which involves mixing the reflected light with the reference light. This method can only detect the absolute value of the frequency shift, but cannot determine whether the shift is positive or negative (i.e., the direction of flow). Therefore, traditional LDV cannot distinguish between the forward wave generated by cardiac ejection and the reflected wave generated at vascular bifurcation, limiting its application in complex hemodynamic modeling.
[0007] Signal-to-noise ratio bottleneck: Because weak backscattered light needs to be received from deep tissues (arteries are often located 2-5 mm under the skin), and this signal is often overwhelmed by the strong reflected light from the epidermis, traditional LDV requires a long integration time to extract the signal, which reduces the temporal resolution and makes it impossible to capture the high-frequency details of the pulse wave (such as the dicrotic notch).
[0008] All of the above factors make it impossible to accurately locate and track the position of arteries in real time. Therefore, in order to address the above technical problems, it is necessary to provide a solution that can track and locate the position of arteries in real time and prevent signal loss. Summary of the Invention
[0009] The purpose of this invention is to provide a method, apparatus, and wearable device for automatic arterial blood vessel tracking based on silicon photonics, which can track and locate the position of arterial blood vessels in real time and prevent signal loss.
[0010] To achieve the above objectives, the present invention provides an automatic arterial blood vessel tracking method based on silicon photonics, the method comprising the following steps:
[0011] S1. Polling each microring resonator in the microring resonator assembly receives the reflected signal from the epidermal tissue, calculates the AC component amplitude of the signal from each microring resonator, and generates a heat map of subcutaneous tissue blood flow distribution.
[0012] S2. Based on the distribution trend of the blood flow distribution heatmap, select the micro-ring resonator with the highest signal-to-noise ratio, and use the measurement channel of the micro-ring resonator as the central measurement channel for monitoring and measurement.
[0013] S3. When the signal-to-noise ratio of the central measurement channel drops below the set threshold, repeat steps S1-S2 to redetermine the central measurement channel.
[0014] As a further improvement of the present invention, the microring resonator assembly is formed by arranging a plurality of adjacent microring resonators, and the sensing area formed by the microring resonators is any one of an N*M array, a circle, an ellipse, or a polygon.
[0015] As a further improvement of the present invention, the step S2 of selecting the microring resonator corresponding to the highest signal-to-noise ratio includes the following steps.
[0016] Based on the distribution trend of the blood flow heatmap, all microring resonators corresponding to the area covered by the heatmap are calibrated. The signal-to-noise ratio of all calibrated microring resonators is compared, and the microring resonator with the highest signal-to-noise ratio is selected.
[0017] As a further improvement of the present invention, the set threshold is the average signal-to-noise ratio of all microring resonators corresponding to the area covered by the heat map distribution.
[0018] As a further improvement of the present invention, steps S2-S3 include the following steps:
[0019] S21. Based on the distribution direction of the blood flow heat map, select the microring resonator with the highest signal-to-noise ratio, and select other microring resonators adjacent to this microring resonator to jointly serve as the central measurement channel.
[0020] S31. When the average signal-to-noise ratio of all micro-ring resonators in the central measurement channel drops below the set threshold, repeat steps S1 and S21 to redetermine the central measurement channel.
[0021] The present invention also provides an automatic arterial vessel tracking device based on silicon photonics. The device includes: a sensing area formed by several microring resonators arranged adjacent to each other and integrated on a silicon photonic chip, for sensing the position of a target artery under skin tissue; a vertical grating coupler for vertically coupling optical signals to the microring resonators; a computing center for storing algorithms and performing calculations on the signals received through the microring resonators; and a control center for controlling the sensing of the microring resonators, the coupling of the vertical grating coupler, and the calculations of the computing center.
[0022] As a further improvement of the present invention, each microring resonator is designed with a size of 10~20μm and has a unique resonant wavelength.
[0023] As a further improvement of the present invention, the calculation and processing of the signal received by the microring resonator includes: calculating the AC component amplitude of the signal of each microring resonator based on the reflected signal received from the epidermal tissue by each microring resonator, and generating a subcutaneous tissue blood flow distribution heat map; calculating the average signal-to-noise ratio of all microring resonators corresponding to the heat map distribution coverage area; and calculating the signal-to-noise ratio of the central measurement channel and comparing it with a set threshold.
[0024] The present invention also provides a wearable device for automatic arterial blood vessel tracking based on silicon photonics, the wearable device including the automatic arterial blood vessel tracking device based on silicon photonics and a fixation structure for fixing the device to human tissue.
[0025] As a further improvement of the present invention, the wearable device includes a watch and headphones.
[0026] Compared with the prior art, the present invention has the following beneficial effects: The present invention integrates a two-dimensional array of micro-ring resonators on a chip based on silicon-based photonics technology. Through automatic scanning, it can quickly locate and track the center position of arteries in the target area. Even if the sensor is displaced, it can quickly switch and track the position of the arteries, which completely solves the problems of alignment and signal loss caused by displacement of traditional single-point sensors. Attached Figure Description
[0027] To more clearly illustrate the technical solutions in the embodiments of the present invention or the prior art, the drawings used in the description of the embodiments or the prior art will be briefly introduced below. Obviously, the drawings described below are only some embodiments recorded in the present invention. For those skilled in the art, other drawings can be obtained based on these drawings without creative effort.
[0028] Figure 1 This is a schematic diagram of the process of an automatic arterial blood vessel tracking method based on silicon photonics according to the present invention;
[0029] Figure 2 This is a schematic diagram of another automatic arterial blood vessel tracking method based on silicon photonics according to the present invention;
[0030] Figure 3 This is a schematic diagram of the automatic arterial vessel localization process in this invention;
[0031] Figure 4 This is a schematic diagram of the automatic arterial blood vessel tracking process in this invention;
[0032] Figure 5 This is a schematic diagram of the structure of an automatic arterial blood vessel tracking device based on silicon photonics according to the present invention. Detailed Implementation
[0033] To enable those skilled in the art to better understand the technical solutions in this disclosure, the technical solutions in the embodiments of this disclosure will be clearly and completely described below with reference to the accompanying drawings. Obviously, the described embodiments are only some embodiments of this disclosure, and not all embodiments. Based on the embodiments in this disclosure, all other embodiments obtained by those skilled in the art without creative effort should fall within the scope of protection of this disclosure.
[0034] like Figure 1 , 3 4. This embodiment discloses an automatic arterial blood vessel tracking method based on silicon-based photonics, the method comprising the following steps:
[0035] S1. Each microring resonator in the polling microring resonator assembly receives the reflected signal from the epidermal tissue, calculates the AC component amplitude of the signal from each microring resonator, and generates a heat map of subcutaneous tissue blood flow distribution.
[0036] In this embodiment, the microring resonator assembly 100 is formed by arranging a plurality of adjacent microring resonators. The sensing area formed by the microring resonators can be any one of an N*M array, a circle, an ellipse, or a polygon. As a preferred option, a square or circular array can be selected. For a square array, each microring resonator can be designed in a square shape, and for a circular array, each microring resonator can be designed in a circular shape.
[0037] In actual testing, due to the difference in reflected signals provided by the arterial blood vessel region under the epidermal tissue compared with other regions, after calculating the AC component amplitude of the signal of each microring resonator, a tissue blood flow distribution heat map that is roughly consistent with the trend of the arterial blood vessels in the target area will be formed.
[0038] S2. Based on the distribution trend of the blood flow heat map, select the micro-ring resonator with the highest signal-to-noise ratio, and use the measurement channel of the micro-ring resonator as the central measurement channel for monitoring and measurement.
[0039] In this embodiment, the blood flow distribution heatmap presents the overall direction of the arteries within the target area. Based on the distribution direction of the blood flow heatmap, all microring resonators corresponding to the area covered by the heatmap are calibrated. The signal-to-noise ratio (SNR) of all calibrated microring resonators is compared, and the microring resonator with the highest SNR is selected. Clearly, the calibrated microring resonators are located roughly within the target area of the arteries, and the overall arrangement of the calibrated microring resonators is also largely consistent with the direction of the arteries within the target area. Therefore, the calibrated microring resonators are essentially capable of providing preliminary localization of the arteries within the target area.
[0040] Based on the above, in order to further accurately focus on the center position of the artery, this embodiment selects the one with the strongest signal-to-noise ratio among all the calibrated micro-ring resonators as the center measurement channel 300 for monitoring and measurement. This can, on the one hand, focus the measurement center on the area with the strongest signal of the artery, providing a more stable signal basis for the monitoring of other indicators, and on the other hand, more accurately locate the center area of the artery.
[0041] S3. When the signal-to-noise ratio of the central measurement channel drops below the set threshold, repeat steps S1-S2 to redetermine the central measurement channel.
[0042] In step S2, after calibrating all the microring resonators corresponding to the heatmap distribution coverage area, it is necessary to calculate the average signal-to-noise ratio (SNR) of all calibrated microring resonators and set this average value as the threshold in this step. Admittedly, in actual testing, this threshold is not immutable and can be flexibly changed according to the specific characteristics of the test area. For example, if the test area is a region with relatively wide arteries (such as the aorta in the human torso), the average SNR of the calibrated microring resonators can be used as the threshold. If the test area is a region with relatively narrow arteries (such as the cochlea), 80% of the highest SNR of the calibrated microring resonators can be used as the threshold. No specific limitations are made here.
[0043] During actual measurement, the coverage area of the microring resonator combination may shift due to human body movement or displacement of the measuring device. The microring resonator with the highest signal-to-noise ratio, which was originally the central measurement channel, may no longer be aligned with the center of the artery within the target area. Therefore, in this embodiment, the signal-to-noise ratio of the central channel is continuously compared with a threshold (e.g., a comparison frequency of 50Hz). If the signal-to-noise ratio falls below the threshold, steps S1-S2 are repeated, polling all microring resonators to reposition the center of the artery within the target area. At this point, the artery trajectory 200B within the target area has changed position, but after steps S1-S2, the microring resonator with the highest signal-to-noise ratio can still be reselected as the central measurement channel 300B. Of course, during the repositioning process, if the displacement is visible to the naked eye, the area covered by the micro-ring resonator assembly will be manually moved back to the approximate location of the artery in the target area, and then repositioned. If the displacement is small and not easily noticeable, but has actually caused a large displacement at the microscopic level, then without manual reset, the center of the artery in the target area can be automatically repositioned through the above steps. Since the comparison frequency in this embodiment is 50Hz or can be set to even faster, the position of the artery can be quickly and seamlessly tracked and located in real time.
[0044] Based on the above embodiments, the present invention further provides an implementation method.
[0045] like Figure 2 This embodiment provides an automatic arterial blood vessel tracking method based on silicon-based photonics, the method comprising the following steps:
[0046] S11. Each microring resonator in the polling microring resonator assembly receives the reflected signal from the epidermal tissue, calculates the AC component amplitude of the signal from each microring resonator, and generates a heat map of subcutaneous tissue blood flow distribution.
[0047] In this embodiment, the microring resonator assembly is formed by arranging several adjacent microring resonators. The sensing area formed by the microring resonators can be any one of an N*M array, a circle, an ellipse, or a polygon. As a preferred option, a square or circular array can be selected. For a square array, each microring resonator can be designed in a square shape, and for a circular array, each microring resonator can be designed in a circular shape.
[0048] In actual testing, because the reflected signals provided by the arterial blood vessels under the epidermal tissue differ from those of other areas, after calculating the AC component amplitude of the signal of each microring resonator, a tissue blood flow distribution heat map that is roughly consistent with the trend of the arterial blood vessels in the target area will be formed.
[0049] S21. Based on the distribution trend of the blood flow heat map, select the microring resonator with the highest signal-to-noise ratio, and select other microring resonators adjacent to this microring resonator as the central measurement channel.
[0050] In this embodiment, the blood flow distribution heatmap presents the overall direction of the arteries within the target area. Based on the distribution direction of the blood flow heatmap, all microring resonators corresponding to the area covered by the heatmap are calibrated. The signal-to-noise ratio (SNR) of all calibrated microring resonators is compared, and the microring resonator with the highest SNR is selected. Clearly, the calibrated microring resonators are located roughly within the target area of the arteries, and the overall arrangement of the calibrated microring resonators is also largely consistent with the direction of the arteries within the target area. Therefore, the calibrated microring resonators are essentially capable of providing preliminary localization of the arteries within the target area.
[0051] Based on the above, in order to further accurately focus on the center position of the artery, this embodiment selects the one with the strongest signal-to-noise ratio among all the calibrated micro-ring resonators as the center measurement channel for monitoring and measurement. This can, on the one hand, focus the measurement center on the area with the strongest signal of the artery, providing a more stable signal basis for the monitoring of other indicators, and on the other hand, more accurately locate the center area of the artery.
[0052] To ensure the test channel receives stronger signals, in this embodiment, after selecting the microring resonator with the highest signal-to-noise ratio, other microring resonators surrounding and adjacent to it are selected as the central measurement channel. This results in a larger and stronger measured signal. Of course, in actual testing, microring resonators two or more rings outwards from the center can also be selected, as long as these selected microring resonators are all within a high signal-to-noise ratio region, thus forming a wider sensing area with more and stronger received signals.
[0053] S31. When the average signal-to-noise ratio of all micro-ring resonators in the central measurement channel drops below the set threshold, repeat steps S11 and S21 to redetermine the central measurement channel.
[0054] In step S21, after calibrating all the microring resonators corresponding to the heatmap distribution coverage area, it is necessary to calculate the average signal-to-noise ratio (SNR) of all calibrated microring resonators and set this average value as the threshold in this step. Admittedly, in actual testing, this threshold is not immutable and can be flexibly changed according to the specific characteristics of the test area. For example, if the test area is a region with relatively wide arteries (such as the aorta in the human torso), the average SNR of the calibrated microring resonators can be used as the threshold. If the test area is a region with relatively narrow arteries (such as the cochlea), 80% of the highest SNR of the calibrated microring resonators can be used as the threshold. No specific limitations are made here.
[0055] During actual measurement, the area covered by the microring resonator assembly may shift due to human movement or displacement of the measuring device. The microring resonator with the highest signal-to-noise ratio, which was originally the central measuring channel, may no longer be aligned with the center of the artery within the target area. Therefore, in this embodiment, the average signal-to-noise ratio of all microring resonators in the central channel is continuously compared with a threshold (e.g., a comparison frequency of 50Hz). If the ratio falls below the threshold, steps S11-S21 are repeated, polling all microring resonators to reposition the center of the artery within the target area. If the displacement is visible to the naked eye, the area covered by the microring resonator assembly is manually moved back to the approximate location of the artery in the target area before repositioning. If the displacement is small and imperceptible, but still significant at the microscopic level, manual repositioning is unnecessary; the center of the artery within the target area can be automatically repositioned using the above methods. Since the comparison frequency in this embodiment is 50Hz or even higher, the position of the artery can be quickly and seamlessly tracked and located in real time.
[0056] Furthermore, to further illustrate the technical effects of this invention, the present invention also provides an automatic arterial blood vessel tracking device based on silicon-based photonics, such as... Figure 5 The device includes,
[0057] A sensing area formed by several micro-ring resonators 2 arranged adjacent to each other and integrated on a silicon-based photonic chip 1 is used to sense the location of the target artery under the skin tissue;
[0058] A vertical grating coupler is used to vertically couple optical signals into a microring resonator;
[0059] A computing center is used to store algorithms and process signals received through the microring resonator using those algorithms.
[0060] The control center controls the sensing of the micro-ring resonator, the coupling of the vertical grating coupler, and the computational processing of the computing center.
[0061] Each microring resonator is designed to be 10-20 μm in size and has a unique resonant wavelength. This wavelength division multiplexing (WDM) design allows the system to read all microring resonators through a single waveguide or to address specific spatial locations by tuning the laser wavelength.
[0062] The calculation and processing of the signals received through the microring resonators includes: calculating the AC component amplitude of the signal from each microring resonator based on the reflected signal received from the epidermal tissue by each microring resonator, generating a subcutaneous tissue blood flow distribution heatmap; calculating the average signal-to-noise ratio of all microring resonators in the heatmap distribution area; calculating the signal-to-noise ratio of the central measurement channel and comparing it with a set threshold, etc.
[0063] Building upon the above, this invention also provides a wearable device for automatic arterial blood vessel tracking based on silicon photonics. This wearable device simply requires encapsulating the silicon photonics-based automatic arterial blood vessel tracking device and a fixed structure designed for a specific scenario. Specific applications include smartwatches, wristbands, and in-ear health monitors. Simply place the microring resonator assembly area on the chip close to the skin, aligning it with the approximate area of the subcutaneous artery. Even while walking or exercising, the device can track and locate the center position of the artery in real time.
[0064] This invention integrates a two-dimensional array of micro-ring resonators on a chip based on silicon-based photonics technology. Through automatic scanning, it can quickly locate and track the center position of arteries within the target area. Even if the sensor is displaced, it can quickly switch and track the position of the arteries, completely solving the problems of alignment and signal loss caused by displacement of traditional single-point sensors.
[0065] It will be apparent to those skilled in the art that this disclosure is not limited to the details of the exemplary embodiments described above, and that this disclosure can be implemented in other specific forms without departing from its spirit or essential characteristics. Therefore, the embodiments should be considered in all respects as exemplary and non-limiting, and the scope of this disclosure is defined by the appended claims rather than the foregoing description. Thus, all variations falling within the meaning and scope of equivalents of the claims are intended to be included within this disclosure. No reference numerals in the claims should be construed as limiting the scope of the claims.
[0066] Furthermore, it should be understood that although this specification describes embodiments, not every embodiment contains only one independent technical solution. This narrative style is merely for clarity. Those skilled in the art should consider the specification as a whole, and the technical solutions in each embodiment can also be appropriately combined to form other embodiments that can be understood by those skilled in the art.
Claims
1. A method for automatic arterial vessel tracking based on silicon photonics, characterized in that: The method includes the following steps: S1. Polling each microring resonator in the microring resonator assembly receives the reflected signal from the epidermal tissue, calculates the AC component amplitude of the signal from each microring resonator, and generates a heat map of subcutaneous tissue blood flow distribution. S2. Based on the distribution trend of the blood flow distribution heatmap, select the micro-ring resonator with the highest signal-to-noise ratio, and use the measurement channel of the micro-ring resonator as the central measurement channel for monitoring and measurement. S3. When the signal-to-noise ratio of the central measurement channel drops below the set threshold, repeat steps S1 and S2 to redetermine the central measurement channel.
2. The automatic arterial vessel tracking method based on silicon photonics according to claim 1, characterized in that: The microring resonator assembly is formed by arranging several adjacent microring resonators, and the sensing area formed by the microring resonators can be any one of an N*M array, a circle, an ellipse, or a polygon.
3. The automatic arterial vessel tracking method based on silicon photonics according to claim 1, characterized in that: Step S2, which involves selecting the microring resonator with the highest signal-to-noise ratio, includes the following steps: Based on the distribution trend of the blood flow heatmap, all microring resonators corresponding to the area covered by the heatmap are calibrated. The signal-to-noise ratio of all calibrated microring resonators is compared, and the microring resonator with the highest signal-to-noise ratio is selected.
4. The automatic arterial vessel tracking method based on silicon photonics according to claim 3, characterized in that: The set threshold is the average signal-to-noise ratio of all microring resonators corresponding to the area covered by the heat map distribution.
5. The automatic arterial vessel tracking method based on silicon photonics according to claim 4, characterized in that: Steps S2-S3 include the following steps: S21. Based on the distribution direction of the blood flow heat map, select the microring resonator with the highest signal-to-noise ratio, and select other microring resonators adjacent to this microring resonator to jointly serve as the central measurement channel. S31. When the average signal-to-noise ratio of all micro-ring resonators in the central measurement channel drops below the set threshold, repeat steps S1 and S21 to redetermine the central measurement channel.
6. An apparatus employing the automatic arterial vessel tracking method based on silicon photonics as described in any one of claims 1-5, characterized in that: The device includes, A sensing area, formed by several micro-ring resonators arranged adjacent to each other and integrated on a silicon-based photonic chip, is used to sense the location of a target artery beneath the skin tissue. A vertical grating coupler is used to vertically couple optical signals into a microring resonator; A computing center is used to store algorithms and process signals received through the microring resonator using those algorithms. The control center controls the sensing of the micro-ring resonator, the coupling of the vertical grating coupler, and the computational processing of the computing center.
7. The automatic arterial blood vessel tracking device based on silicon photonics according to claim 6, characterized in that: Each microring resonator is designed to be 10-20 μm in size and has a unique resonant wavelength.
8. The automatic arterial blood vessel tracking device based on silicon photonics according to claim 7, characterized in that: The calculation and processing of the signal received through the microring resonator includes... Based on the reflected signal received from the epidermal tissue by each microring resonator, the amplitude of the AC component of the signal of each microring resonator is calculated to generate a heat map of subcutaneous tissue blood flow distribution. Calculate the average signal-to-noise ratio of all microring resonators corresponding to the area covered by the heat map distribution; The signal-to-noise ratio of the central measurement channel is calculated and compared with a set threshold.
9. A wearable device for automatic arterial blood vessel tracking based on silicon photonics, characterized in that: The wearable device includes the silicon-based photonics-based automatic arterial tracking device as described in claim 8, and a fixation structure for fixing the device to human tissue.
10. The wearable device for automatic arterial blood vessel tracking based on silicon photonics according to claim 9: characterized in that: The wearable devices include watches and headphones.
